Viewing Study NCT07185932


Ignite Creation Date: 2025-12-24 @ 9:28 PM
Ignite Modification Date: 2025-12-25 @ 7:13 PM
Study NCT ID: NCT07185932
Status: RECRUITING
Last Update Posted: 2025-09-22
First Post: 2025-08-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy and Safety of Rifaximin in Treating MAFLD
Sponsor: Shanghai Changzheng Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module